Increase in Renal Medullary Nitric Oxide Synthase Activity Protects From Norepinephrine-Induced Hypertension
- 1 January 2000
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 35 (1) , 418-423
- https://doi.org/10.1161/01.hyp.35.1.418
Abstract
Studies were performed in conscious Sprague-Dawley rats to determine the role of the alpha(2)-adrenergic receptor-mediated increase in the renal medullary nitric oxide synthase (NOS) activity as a counterregulatory mechanism of blood pressure control in response to increased renal adrenergic stimulation. A subpressor dose of norepinephrine (NE, 8 microg. kg(-1). h(-1)) was infused intravenously, and NOS activity was determined with arginine-citrulline conversion by high-performance liquid chromatography in renal cortical and outer and inner medullary tissues. It was found that after 7 days of intravenous NE infusion, NOS activity was significantly higher in both the outer and inner medullary tissues (158+/-45 versus 30+/-24 pmol. mg(-1). h(-1) [outer medulla] and 5.1+/-0.7 versus 2.0+/-0.5 nmol. mg(-1). h(-1) [inner medulla] for NE-treated versus control rats, respectively). To determine whether the increase of NOS activity was mediated through renal medullary alpha(2)-receptors, the receptor antagonist rauwolscine (RAU, 1 microg. kg(-1). min(-1)) was infused via an implanted renal medullary interstitial catheter, and the consequences of intravenous NE administration were evaluated. NOS activity was significantly lower in the RAU-infused animals and did not increase with infusion of NE. To determine the systemic effects of the renal medullary alpha(2)-receptors, studies were performed to determine the consequences of chronic intravenous infusion of subpressor amounts of NE in the presence and absence of renal medullary alpha(2)-receptor inhibition. Under conditions in which RAU was continuously infused into the renal medulla, the same subpressor dose of NE caused sustained and reversible hypertension (mean arterial pressure increased from 120+/-3 to 131+/-3 mm Hg). Chronic blunting of the renal medullary NOS activity with N(G)-nitro-L-arginine methyl ester (75 microg. kg(-1). h(-1)) also enabled NE to produce a significant rise in mean arterial pressure (from 117+/-2 to 134+/-4 mm Hg). We conclude that the hypertensive effects of moderate elevations of renal adrenergic activity were chronically buffered by the alpha(2)-receptor-mediated increase in NOS activity within the renal medulla.Keywords
This publication has 15 references indexed in Scilit:
- Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.Journal of Clinical Investigation, 1997
- Phospholamban ablation enhances relaxation in the murine soleusAmerican Journal of Physiology-Cell Physiology, 1997
- Localization of neuronal nitric oxide synthase-immunoreactivity within sub-populations of noradrenergic A1 and A2 neurons in the ratBrain Research, 1996
- Interactive Control of Renal Function by α2-Adrenergic System and Nitric OxideJournal of Cardiovascular Pharmacology, 1995
- Iodoacetate-induced skeletal muscle contracture: changes in ADP, calcium, phosphate, and pHAmerican Journal of Physiology-Cell Physiology, 1995
- Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats.Hypertension, 1994
- Termination of magnet- unresponsive pacemaker endless loop tachycardia by carotid sinus massageThe American Journal of Medicine, 1989
- Renal alpha 2-adrenergic receptors and hypertension.Hypertension, 1987
- The cortical and medullary blood flow at different levels of renal nerve activityActa Physiologica Scandinavica, 1984
- Chronic intravenous infusion of noradrenaline produces labile hypertension in conscious ratsLife Sciences, 1981